Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Israel extends second COVID-19 booster to elderly in care facilities

Published 12/31/2021, 05:19 AM
Updated 12/31/2021, 05:20 AM
© Reuters. Moshe Geva Rosso, 62 years old receives a fourth dose of the coronavirus disease (COVID-19) vaccine after Israel's Health Ministry approved a second booster for the immunocompromised, at Sheba Medical Center in Ramat Gan, Israel December 31, 2021. REUTERS

JERUSALEM (Reuters) -Israel is extending its offer of a fourth COVID-19 vaccine dose to elderly people in care facilities, Health Minister Nitzan Horowitz said on Friday, citing their high exposure and vulnerability to infections.

On Thursday, the Health Ministry's director-general, Nachman Ash, approved https://reut.rs/3EK1R3n fourth doses for people with weakened immune systems and the administering of those shots began on Friday.

An Israeli hospital administered fourth shots to a test group https://reut.rs/3mKSzhq of health workers on Monday, in what it called the firstmajor study into whether a second round of boosters will helpcontend with the Omicron coronavirus variant.

© Reuters. Moshe Geva Rosso, 62 years old receives a fourth dose of the coronavirus disease (COVID-19) vaccine after Israel's Health Ministry approved a second booster for the immunocompromised, at Sheba Medical Center in Ramat Gan, Israel December 31, 2021. REUTERS/Nir Elias

Results are expected within two weeks. A Health Ministry expert panel last week recommended thatIsrael offer a fourth shot of the vaccine developed by Pfizer (NYSE:PFE) and BioNTech to medical workers and those over 60 or with compromised immune systems.

Israel was the fastest country to roll out initialvaccinations a year ago and became one of the first to launch abooster programme after observing that immunity waned over time. Its policies on boosters have been closely watched by othernations, including the United States, that are considering whento offer additional doses.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.